Emagine Solutions Technology announced that the Arizona Commerce Authority has awarded the maternal health innovator a coveted $250,000 grant.
The funds will allow Emagine and its partners at The Preeclampsia Foundation to conduct vital research into the impact of technology and wearable devices on pregnancy health, improving outcomes both locally and nationwide.
Emagine is also seeking applicants for its upcoming maternal health technology study. Conducted alongside Dr. Sharon Thompson OBGYN – Science and Tech Advisor for Emagine – the research will leverage The Journey Pregnancy app to assess the experiences of Arizona women using wearable devices to monitor their pregnancy health.
Patients must be 18 or older, live in Arizona, and currently pregnant.
Participants will receive a $50 gift card, an iHealth blood pressure monitor, a Preeclampsia Foundation blood pressure monitoring kit, and a Fitbit Charge 6 Premium Fitness Tracker, all free of charge.
Research areas include how wearable devices, blood pressure cuff kits, and access to The Journey Pregnancy AI-driven maternal health app improves wellness, increases health literacy, and impacts patient attendance at their prenatal visits, the cost savings related to deploying these technologies to Arizona’s pregnant women, and the impact of remote monitoring on early detection and timely intervention for hypertensive disorders.
“Our state has the 11th worst maternal outcomes in the country, so we believe there is an opportunity to make an impact through this project,” says Emagine Solutions Technology Co-founder and CEO Courtney Williams. “Hypertension in particular is a critical area to study, as women who experience a condition like preeclampsia are 3 to 4 times more likely to have heart issues later on in life. Ultimately, the more feedback and data we can gather, the better we can understand how to use technology to make pregnancy care safer, lower cost, and improve outcomes.”
